• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-2包膜糖蛋白(Env)中的单个氨基酸取代N659D会损害病毒释放并阻碍BST-2拮抗作用。

Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.

作者信息

Dufrasne François E, Lombard Catherine, Goubau Patrick, Ruelle Jean

机构信息

AIDS Reference Laboratory, Medical Microbiology Unit (MBLG), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Avenue Hippocrate 54 B1.54.05, B-1200 Brussels, Belgium.

Pôle de Pédiatrie (PEDI), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Avenue Mounier 52 B1.52.03, B-1200 Brussels, Belgium.

出版信息

Viruses. 2016 Oct 14;8(10):285. doi: 10.3390/v8100285.

DOI:10.3390/v8100285
PMID:27754450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5086617/
Abstract

BST-2 or tetherin is a host cell restriction factor that prevents the budding of enveloped viruses at the cell surface, thus impairing the viral spread. Several countermeasures to evade this antiviral factor have been positively selected in retroviruses: the human immunodeficiency virus type 2 (HIV-2) relies on the envelope glycoprotein (Env) to overcome BST-2 restriction. The Env gp36 ectodomain seems involved in this anti-tetherin activity, however residues and regions interacting with BST-2 are not clearly defined. Among 32 HIV-2 ROD Env mutants tested, we demonstrated that the asparagine residue at position 659 located in the gp36 ectodomain is mandatory to exert the anti-tetherin function. Viral release assays in cell lines expressing BST-2 showed a loss of viral release ability for the HIV-2 N659D mutant virus compared to the HIV-2 wild type virus. In inactivated H9 cells, those differences were lost. Subtilisin treatment of infected cells demonstrated that the N659D mutant was more tethered at the cell surface. Förster resonance energy transfer (FRET) experiments confirmed a direct molecular link between Env and BST-2 and highlighted an inability of the mutant to bind BST-2. We also tested a virus presenting a truncation of 109 amino acids at the C-terminal part of Env, a cytoplasmic tail partial deletion that is spontaneously selected in vitro. Interestingly, viral release assays and FRET experiments indicated that a full Env cytoplasmic tail was essential in BST-2 antagonism. In HIV-2 infected cells, an efficient Env-mediated antagonism of BST-2 is operated through an intermolecular link involving the asparagine 659 residue as well as the C-terminal part of the cytoplasmic tail.

摘要

BST-2或栓系蛋白是一种宿主细胞限制因子,可阻止包膜病毒在细胞表面出芽,从而损害病毒传播。逆转录病毒中已积极选择了几种逃避这种抗病毒因子的对策:2型人类免疫缺陷病毒(HIV-2)依靠包膜糖蛋白(Env)来克服BST-2的限制。Env gp36胞外域似乎参与了这种抗栓系蛋白活性,然而,与BST-2相互作用的残基和区域尚未明确界定。在测试的32个HIV-2 ROD Env突变体中,我们证明位于gp36胞外域第659位的天冬酰胺残基对于发挥抗栓系蛋白功能是必需的。在表达BST-2的细胞系中进行的病毒释放试验表明,与HIV-2野生型病毒相比,HIV-2 N659D突变病毒的病毒释放能力丧失。在灭活的H9细胞中,这些差异消失了。对感染细胞进行枯草杆菌蛋白酶处理表明,N659D突变体在细胞表面的栓系作用更强。荧光共振能量转移(FRET)实验证实了Env与BST-2之间存在直接的分子联系,并突出显示突变体无法结合BST-2。我们还测试了一种病毒变体,该变体在Env的C末端部分截短了109个氨基酸,这是在体外自发选择的细胞质尾巴部分缺失。有趣的是,病毒释放试验和FRET实验表明,完整的Env细胞质尾巴对于BST-2拮抗作用至关重要。在HIV-2感染的细胞中,有效的Env介导的BST-2拮抗作用是通过涉及天冬酰胺659残基以及细胞质尾巴C末端部分的分子间联系来实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/b01bc709f4e6/viruses-08-00285-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/7d83677bec6b/viruses-08-00285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/5ed102bdb492/viruses-08-00285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/e383c364db20/viruses-08-00285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/3ac0f253ea41/viruses-08-00285-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/946160a05067/viruses-08-00285-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/f337d9c4814d/viruses-08-00285-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/b01bc709f4e6/viruses-08-00285-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/7d83677bec6b/viruses-08-00285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/5ed102bdb492/viruses-08-00285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/e383c364db20/viruses-08-00285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/3ac0f253ea41/viruses-08-00285-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/946160a05067/viruses-08-00285-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/f337d9c4814d/viruses-08-00285-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/5086617/b01bc709f4e6/viruses-08-00285-g007.jpg

相似文献

1
Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.HIV-2包膜糖蛋白(Env)中的单个氨基酸取代N659D会损害病毒释放并阻碍BST-2拮抗作用。
Viruses. 2016 Oct 14;8(10):285. doi: 10.3390/v8100285.
2
Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.BST-2/栓系蛋白的拮抗作用是原发性HIV-2分离株包膜糖蛋白的保守功能。
J Virol. 2016 Nov 28;90(24):11062-11074. doi: 10.1128/JVI.01451-16. Print 2016 Dec 15.
3
Determinants in HIV-2 Env and tetherin required for functional interaction.HIV-2包膜蛋白与限制素功能相互作用所需的决定因素。
Retrovirology. 2015 Aug 7;12:67. doi: 10.1186/s12977-015-0194-0.
4
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.猴免疫缺陷病毒 SIVsmm 的预适应促进了人类免疫缺陷病毒 2 型通过包膜介导拮抗人 tetherin
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00276-18. Print 2018 Sep 15.
5
Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.人类免疫缺陷病毒2型包膜糖蛋白对人束缚素的拮抗作用及细胞内隔离
J Virol. 2009 Nov;83(22):11966-78. doi: 10.1128/JVI.01515-09. Epub 2009 Sep 9.
6
Modulation of the NF-κB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism.HIV-2包膜糖蛋白对NF-κB信号通路的调节及其对BST-2的不完全拮抗作用。
Virology. 2018 Jan 1;513:11-16. doi: 10.1016/j.virol.2017.09.024. Epub 2017 Oct 11.
7
Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.埃博拉病毒糖蛋白以不依赖于 tetherin 表面去除的序列非依赖性方式拮抗 BST-2/Tetherin 的限制。
J Virol. 2010 Jul;84(14):7243-55. doi: 10.1128/JVI.02636-09. Epub 2010 May 5.
8
Adaptation of human and simian immunodeficiency viruses for resistance to tetherin/BST-2.人类免疫缺陷病毒和猿猴免疫缺陷病毒对限制素/BST-2的抗性适应性
Curr HIV Res. 2012 Jun;10(4):277-82. doi: 10.2174/157016212800792496.
9
Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens.内吞途径在人类慢病毒病原体拮抗 BST-2 中的作用。
J Virol. 2011 Oct;85(19):9834-46. doi: 10.1128/JVI.02633-10. Epub 2011 Aug 3.
10
Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.Nef 通过与 tetherin 的直接物理相互作用以及网格蛋白介导的内吞作用拮抗 tetherin/BST-2。
PLoS Pathog. 2013;9(7):e1003487. doi: 10.1371/journal.ppat.1003487. Epub 2013 Jul 11.

引用本文的文献

1
Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.免疫与病毒感染:通过 CRISPR-Cas 系统调节抗病毒反应。
Viruses. 2021 Jul 15;13(7):1373. doi: 10.3390/v13071373.
2
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.猴免疫缺陷病毒 SIVsmm 的预适应促进了人类免疫缺陷病毒 2 型通过包膜介导拮抗人 tetherin
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00276-18. Print 2018 Sep 15.
3
CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.

本文引用的文献

1
Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.一种神经毒性猴免疫缺陷病毒包膜对BST-2的增强拮抗作用。
J Clin Invest. 2016 Jun 1;126(6):2295-307. doi: 10.1172/JCI83725. Epub 2016 May 9.
2
Early Vertebrate Evolution of the Host Restriction Factor Tetherin.宿主限制因子拴系蛋白的早期脊椎动物进化
J Virol. 2015 Dec;89(23):12154-65. doi: 10.1128/JVI.02149-15. Epub 2015 Sep 23.
3
Determinants in HIV-2 Env and tetherin required for functional interaction.HIV-2包膜蛋白与限制素功能相互作用所需的决定因素。
CRISPR/Cas9-推动正痘病毒基因组编辑用于疫苗和载体开发。
Viruses. 2018 Jan 22;10(1):50. doi: 10.3390/v10010050.
Retrovirology. 2015 Aug 7;12:67. doi: 10.1186/s12977-015-0194-0.
4
Understanding FRET as a research tool for cellular studies.了解荧光共振能量转移作为细胞研究的一种研究工具。
Int J Mol Sci. 2015 Mar 25;16(4):6718-56. doi: 10.3390/ijms16046718.
5
The end of Nef's tether.内夫束缚的尽头。
Trends Microbiol. 2014 Dec;22(12):662-4. doi: 10.1016/j.tim.2014.10.008. Epub 2014 Nov 12.
6
Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification.用于HIV-2血浆RNA定量的超灵敏数字液滴PCR检测方法的验证
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19675. doi: 10.7448/IAS.17.4.19675. eCollection 2014.
7
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.利用CRISPR-Cas9基因组编辑技术通过组合基因损伤构建髓系恶性肿瘤小鼠模型。
Nat Biotechnol. 2014 Sep;32(9):941-6. doi: 10.1038/nbt.2951. Epub 2014 Jun 22.
8
Counteraction of the multifunctional restriction factor tetherin.多功能限制因子拴系蛋白的对抗作用
Front Microbiol. 2014 Apr 10;5:163. doi: 10.3389/fmicb.2014.00163. eCollection 2014.
9
Origin and diversity of human retroviruses.人类逆转录病毒的起源与多样性。
AIDS Rev. 2014 Jan-Mar;16(1):23-34.
10
HIV accessory proteins versus host restriction factors.HIV 辅助蛋白与宿主限制因子。
Curr Opin Virol. 2013 Dec;3(6):692-9. doi: 10.1016/j.coviro.2013.08.004. Epub 2013 Nov 15.